Blue Chip Partners »

Vaneck Vectors Pharmaceutical etf shares owned by Blue Chip Partners

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Blue Chip Partners from 13F filings

Historical chart of Blue Chip Partners investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Blue Chip Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Blue Chip Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $450k 5.0k 90.36
2024-12-31 $2.1M 25k 86.28

More positions owned by Blue Chip Partners

Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Broadcom (AVGO)
Apple (AAPL)
Microsoft Corporation (MSFT)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Abbvie (ABBV)
Capital Grp Fixed Incm Etf T Municipal Income (CGMU)
Morgan Stanley Com New (MS)
Select Sector Spdr Tr Energy (XLE)
Home Depot (HD)
Amazon (AMZN)
Costco Wholesale Corporation (COST)
Visa Com Cl A (V)
Blackrock (BLK)

View all positions for Blue Chip Partners

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Morgan Stanley
Wells Fargo & Company
Clal Insurance Enterprises Holdings
J.Safra Asset Management
Avalon Trust
Jpmorgan Chase & Co
J. Goldman & Co
Miller Investment Management
Jane Street
Revere Asset Management
Adamsbrown Wealth Consultants
Bnp Paribas Arbitrage, Snc
Prime Capital Investment Advisors

View all funds holding Vaneck Vectors Pharmaceutical etf